GSK - 36 Year Stock Split History | GSK

Stock split history for GSK since 1986. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
GSK Annual Stock Splits
GSK Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $59.709B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $153.119B 9.29
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.856B 0.00
QIAGEN (QGEN) Netherlands $9.360B 15.67
Ginkgo Bioworks Holdings (DNA) United States $5.587B 0.00
Arcus Biosciences (RCUS) United States $1.842B 35.96
Myovant Sciences (MYOV) United Kingdom $1.684B 0.00
Emergent Biosolutions (EBS) United States $1.036B 6.01
ADC Therapeutics SA (ADCT) Switzerland $0.376B 0.00
Zymeworks (ZYME) Canada $0.336B 0.00
Enzo Biochem (ENZ) United States $0.107B 0.00
Gelesis Holdings (GLS) United States $0.078B 0.00
SQZ Biotechnologies (SQZ) United States $0.065B 0.00
Ambrx Biopharma (AMAM) United States $0.042B 0.00